Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum

Clinical trial NCT00448253 · COMPLETED

Trial details

NCT number: NCT00448253
Sponsor: Emergent BioSolutions
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Symptoms of Inhalational Anthrax

Start date: 2007-07-01
Primary completion: 2008-08-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.